← Evidence map

ArticleTherapeutic innovation & regulatory science2022

Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA.

Zhong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35118630